Case Study
250 Conditions supported across 40 therapeutic areas
270 Engagements in the last 5 years
100+ Pre-commercial assets supported in the last 5 years
Identify the drivers and barriers for patients to undergo genetic testing in breast, prostate, and ovarian cancer and test receptivity to educational materials focused on the importance of genetic testing (particularly BRCA and HRD).
Project findings informed refinement to awareness campaigns and informed a better understanding of inflection points in the patient journey for each tumor type.